These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14443778)

  • 21. EFFECTS OF NON-RESPIRATORY VACCINES ON NATURAL IMMUNITY. RES PROJ REP MR 005.09-1203.2.
    RYTEL MW; LYTLE RI
    Rep U S Nav Med Res Lab; 1963 Aug; 13():1-10. PubMed ID: 24547138
    [No Abstract]   [Full Text] [Related]  

  • 22. THE EFFECT OF DELAYED IMMUNIZATIONS ON ACUTE RESPIRATORY DISEASE IN NAVY RECRUITS. MR 005. 09-1203.9.
    PIERCE WE; EDWARDS EA
    Rep U S Nav Med Res Lab; 1964 Oct; 10():1-12. PubMed ID: 24547283
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent experiences with live adenovirus vaccines in navy recruits.
    Rosenbaum MJ; Edwards EA; Hoeffler DF CAPT
    Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324
    [No Abstract]   [Full Text] [Related]  

  • 24. T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases.
    Rudenko LG; Zoshchenkova NY; Tunkun TI; Shamanova MG; Zykov MP; Starshov PD
    Acta Virol; 1978 Mar; 22(2):167-9. PubMed ID: 26203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of immunization of volunteers with live attenuated adenovirus vaccine type IV, V and VII. (Preliminary communication)].
    SMORODINTSEV AA; SELIVANOV AA
    Vopr Virusol; 1959; 4():648-52. PubMed ID: 13832219
    [No Abstract]   [Full Text] [Related]  

  • 26. A guinea pig potency test for adenovirus vaccine.
    BINN LN; HILLEMAN MR
    J Immunol; 1960 Jan; 84():20-6. PubMed ID: 13800797
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of an adenovirus vaccine in a dispensary population.
    STALLONES RA; LENNETTE EH; NITZ RE; HOLGUIN AH
    Am J Hyg; 1960 Jul; 72():100-10. PubMed ID: 13833681
    [No Abstract]   [Full Text] [Related]  

  • 28. [INCIDENCE OF ADENOVIRUS INFECTIONS IN A CAMP OF CANADIAN RECRUITS].
    PAVILANIS V; DAVIGNON L; PODOSKI MO
    Rev Can Biol; 1964 Sep; 23():291-8. PubMed ID: 14237162
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of the significance of the recall phenomenon in the antibody response to adenovirus vaccine and infection.
    van der VEEN ; PRINS A
    J Immunol; 1960 Jun; 84():562-8. PubMed ID: 13841541
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza A virus aboard a US Navy ship in 1972 and the antibody response of the crew to influenza vaccine.
    Green IJ; Hung SC; Irving GS; Davenport JV
    Mil Med; 1975 Mar; 140(3):179-81. PubMed ID: 803663
    [No Abstract]   [Full Text] [Related]  

  • 31. Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.
    Pierce WE; Rosenbaum MJ; Edwards EA; Peckinpaugh RO; Jackson GG
    Am J Epidemiol; 1968 Jan; 87(1):237-46. PubMed ID: 4295428
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunologic study on respiratory viruses isolated in Alaska.
    METCALF TG; SCHMIDT JP
    Tech Rep Arct Aeromed Lab US; 1961 Oct; 60-37():12p. PubMed ID: 13935173
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody titer in allergic children given adenovirus vaccine.
    CHOBOT R; GOLDZIER SE; SCHWARTZ T; OSBORNE D
    J Allergy; 1959; 30(2):97-102. PubMed ID: 13630640
    [No Abstract]   [Full Text] [Related]  

  • 34. An interpretation of the significance of influenza virus variation for the development of an effective vaccine.
    SALK JE
    Bull N Y Acad Med; 1952 Nov; 28(11):748-65. PubMed ID: 12987937
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of some pulmonary morphological and biochemical changes in white mice during immunization with respiratory viruses (influenzal Myxovirus, type A, and adenovirus, type 5)].
    Petrescu A
    Stud Cercet Inframicrobiol; 1967; 18(4):299-322. PubMed ID: 4295423
    [No Abstract]   [Full Text] [Related]  

  • 36. EPIDEMIC VIRUS INFLUENZA IN NOVA SCOTIA AND NEW BRUNSWICK DURING THE FIRST SIX MONTHS IN 1963.
    DOBSON P; KERENYI N; VANROOYEN CE; LEE S
    Med Serv J Can; 1963 Nov; 19():799-808. PubMed ID: 14077436
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of vaccine-induced and natural infection with adenovirus type 4 in naval recruits.
    Rosenbaum MJ; De Berry P; Sullivan EJ; Edwards EA; Pierce WE; Muldoon RL; Jackson GG; Peckinpaugh RO
    Am J Epidemiol; 1968 Jul; 88(1):45-54. PubMed ID: 4298479
    [No Abstract]   [Full Text] [Related]  

  • 38. FIELD TRIAL WITH ABOB (SK8898-A) AS A PROPHYLACTIC AGENT AGAINST INFLUENZA A2 AND ADENOVIRUS INFECTION.
    MEIKLEJOHN G; MCCANN WP; SHKOLNIK S
    Mil Med; 1963 Sep; 128():890-4. PubMed ID: 14049668
    [No Abstract]   [Full Text] [Related]  

  • 39. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982.
    Meiklejohn G
    J Infect Dis; 1983 Nov; 148(5):775-84. PubMed ID: 6313818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EPIDEMIOLOGY AND PREVENTION OF ACUTE RESPIRATORY DISEASE IN NAVAL RECRUITS. 3. THE EFFECT OF DELAYED IMMUNIZATIONS OF ACUTE RESPIRATORY DISEASE IN NAVAL RECRUITS.
    PIERCE WE; MILLER LF
    Am J Public Health Nations Health; 1965 Jan; 55(1):60-6. PubMed ID: 14251985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.